Skip to main content
Top
Published in: BMC Cancer 1/2006

Open Access 01-12-2006 | Research article

KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma

Authors: Minglei Guo, Jinjun Li, Dafang Wan, Jianren Gu

Published in: BMC Cancer | Issue 1/2006

Login to get access

Abstract

Background

Our previous cDNA array results indicated KIAA0101 as one of the differentially expressed genes in human hepatocellular carcinoma (HCC) as compared with non-cancerous liver. However, it is necessary to study its expression at protein level in HCC and its biological function for HCC cell growth.

Method

Western blot and tissue array were performed to compare KIAA0101 protein expression level in paired human HCC and non-cancerous liver tissues from the same patients. Investigation of its subcellular localization was done by using dual fluorescence image examination and enriched mitochondrial protein Western blot analysis. The in vitro cell growth curve was used for examing the effect of over-expression of KIAA0101 in HCC cells. FACS was used to analyze the cell cycle pattern in KIAA0101 expression positive (+) and negative (-) cell populations isolated by the pMACSKKII system after KIAA0101 cDNA transfection.

Results

Western blot showed KIAA0101 protein expression was down-regulated in HCC tissues as compared with their counterpart non-cancerous liver tissues in 25 out of 30 cases. Tissue array also demonstrated the same pattern in 161 paired samples. KIAA0101 was predominantly localized in mitochondria and partially in nuclei. KIAA0101 cDNA transfection could inhibit the HCC cell growth in vitro. In cell cycle analysis, it could arrest cells at the G1 to S phase transition.

Conclusion

KIAA0101 protein expression was down-regulated in HCC. This gene could inhibit the HCC cell growth in vitro and presumably by its blocking effect on cell cycle.
Appendix
Available only for authorised users
Literature
1.
go back to reference Li D, Cao Y, He L, Wang NJ, Gu JR: Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis. 1993, 14 (2): 169-173.CrossRefPubMed Li D, Cao Y, He L, Wang NJ, Gu JR: Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis. 1993, 14 (2): 169-173.CrossRefPubMed
2.
go back to reference Qin LF, Ng IO, Fan ST, Ng M: P21/WAF1, P53 and PCNA expression and P53 mutation status in hepatocellular carcinoma. Int J Cancer. 1998, 79 (4): 424-428. 10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4.CrossRefPubMed Qin LF, Ng IO, Fan ST, Ng M: P21/WAF1, P53 and PCNA expression and P53 mutation status in hepatocellular carcinoma. Int J Cancer. 1998, 79 (4): 424-428. 10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4.CrossRefPubMed
3.
go back to reference Tannapfel A, Grund D, Katalinic A, Uhlmann D, Kockerling F, Haugwitz U, Wasner M, Hauss J, Engeland K, Wittekind C: Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer. 2000, 89 (4): 350-355. 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3.CrossRefPubMed Tannapfel A, Grund D, Katalinic A, Uhlmann D, Kockerling F, Haugwitz U, Wasner M, Hauss J, Engeland K, Wittekind C: Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer. 2000, 89 (4): 350-355. 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3.CrossRefPubMed
4.
go back to reference Wong CM, Fan ST, Ng IO: β-catenin mutation and overexpression in hepatocellular carcinoma. Cancer. 2001, 92 (1): 136-145. 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R.CrossRefPubMed Wong CM, Fan ST, Ng IO: β-catenin mutation and overexpression in hepatocellular carcinoma. Cancer. 2001, 92 (1): 136-145. 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R.CrossRefPubMed
5.
go back to reference Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM, Tsou HC: PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene. 1999, 18 (20): 3181-3185. 10.1038/sj.onc.1202659.CrossRefPubMed Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM, Tsou HC: PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene. 1999, 18 (20): 3181-3185. 10.1038/sj.onc.1202659.CrossRefPubMed
6.
go back to reference Xu Liang, Hui Lijian, Wang Shaohui, Gong Jialei, Jin Ying, Wang Yanping, Ji Yuan, Wu Xin, Han Zheguang, Hu Gengxi: Expression Profiling Suggested a Regulatory Role of Liver-enriched Transcription Factors in Human Hepatocellular Carcinoma1. Cancer Res. 2001, 61 (7): 3176-3181.PubMed Xu Liang, Hui Lijian, Wang Shaohui, Gong Jialei, Jin Ying, Wang Yanping, Ji Yuan, Wu Xin, Han Zheguang, Hu Gengxi: Expression Profiling Suggested a Regulatory Role of Liver-enriched Transcription Factors in Human Hepatocellular Carcinoma1. Cancer Res. 2001, 61 (7): 3176-3181.PubMed
7.
go back to reference Mizutani K, Onda M, Asaka S, Akaishi J, Miyamoto S, Yoshida A, Nagahama M, Ito K, Emi M: Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer. 2005, 103 (9): 1785-90. 10.1002/cncr.20988.CrossRefPubMed Mizutani K, Onda M, Asaka S, Akaishi J, Miyamoto S, Yoshida A, Nagahama M, Ito K, Emi M: Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer. 2005, 103 (9): 1785-90. 10.1002/cncr.20988.CrossRefPubMed
8.
go back to reference Petroziello Joseph, Yamane Andrew, Westendorf Lori, Thompson Melissa, McDonagh Charlotte, Cerveny Charles, Law Che-Leung, Wah Alan, Paul Carter: Suppression subtractive hybridization and expression profiling identifies a unique set of genes over-expressed in non-small-cell lung cancer. Oncogene. 2004, 23 (46): 7734-7745. 10.1038/sj.onc.1207921.CrossRefPubMed Petroziello Joseph, Yamane Andrew, Westendorf Lori, Thompson Melissa, McDonagh Charlotte, Cerveny Charles, Law Che-Leung, Wah Alan, Paul Carter: Suppression subtractive hybridization and expression profiling identifies a unique set of genes over-expressed in non-small-cell lung cancer. Oncogene. 2004, 23 (46): 7734-7745. 10.1038/sj.onc.1207921.CrossRefPubMed
9.
go back to reference Simpson F, Lammerts van Bueren K, Butterfield N, Bennetts JS, Bowles J, Adolphe C, Simms LA, Young J, Walsh MD, Leggett B, Fowles LF, Wicking C: The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res. 2006, 312 (1): 73-85. 10.1016/j.yexcr.2005.09.020.CrossRefPubMed Simpson F, Lammerts van Bueren K, Butterfield N, Bennetts JS, Bowles J, Adolphe C, Simms LA, Young J, Walsh MD, Leggett B, Fowles LF, Wicking C: The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res. 2006, 312 (1): 73-85. 10.1016/j.yexcr.2005.09.020.CrossRefPubMed
10.
go back to reference Notterman DA, Alon U, Sierk AJ, Levine AJ: transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001, 61 (7): 3124-3130.PubMed Notterman DA, Alon U, Sierk AJ, Levine AJ: transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001, 61 (7): 3124-3130.PubMed
11.
go back to reference Chen G, Gharib TG, Huang CC, Tylors JMG, Misek DE, Kardia SLR, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG: discordant protein and mRNA expression in lung adenocarcinaomas. Molecular & cellular Proteomics. 2002, 1: 304-313. 10.1074/mcp.M200008-MCP200.CrossRef Chen G, Gharib TG, Huang CC, Tylors JMG, Misek DE, Kardia SLR, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG: discordant protein and mRNA expression in lung adenocarcinaomas. Molecular & cellular Proteomics. 2002, 1: 304-313. 10.1074/mcp.M200008-MCP200.CrossRef
Metadata
Title
KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma
Authors
Minglei Guo
Jinjun Li
Dafang Wan
Jianren Gu
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-109

Other articles of this Issue 1/2006

BMC Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine